

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.79651592 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.79651592 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56521707 |
| 4 | protein prenylation (GO:0018342) | 4.52132910 |
| 5 | prenylation (GO:0097354) | 4.52132910 |
| 6 | autophagic vacuole fusion (GO:0000046) | 4.32152285 |
| 7 | organelle membrane fusion (GO:0090174) | 4.21992008 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 4.19317329 |
| 9 | cullin deneddylation (GO:0010388) | 4.15127316 |
| 10 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.14523320 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.10198763 |
| 12 | DNA replication initiation (GO:0006270) | 4.07673889 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04179445 |
| 14 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.99751308 |
| 15 | protein deneddylation (GO:0000338) | 3.94965371 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 3.93976499 |
| 17 | DNA strand elongation (GO:0022616) | 3.92432344 |
| 18 | response to interferon-beta (GO:0035456) | 3.84674001 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.83998627 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82905598 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.81131934 |
| 22 | DNA deamination (GO:0045006) | 3.78171407 |
| 23 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.75525696 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71401652 |
| 25 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.70861180 |
| 26 | mitotic metaphase plate congression (GO:0007080) | 3.65681369 |
| 27 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.65027539 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 3.64322164 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.62611223 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.62555961 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.62254537 |
| 32 | mitotic recombination (GO:0006312) | 3.61125101 |
| 33 | telomere maintenance via recombination (GO:0000722) | 3.55599187 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.55203152 |
| 35 | DNA unwinding involved in DNA replication (GO:0006268) | 3.54017861 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53900753 |
| 37 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.53549806 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.53549806 |
| 39 | DNA replication checkpoint (GO:0000076) | 3.51303187 |
| 40 | negative T cell selection (GO:0043383) | 3.50561408 |
| 41 | termination of RNA polymerase III transcription (GO:0006386) | 3.50466251 |
| 42 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.50466251 |
| 43 | negative regulation of T cell apoptotic process (GO:0070233) | 3.48181175 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47567784 |
| 45 | mast cell activation (GO:0045576) | 3.45021874 |
| 46 | nucleobase biosynthetic process (GO:0046112) | 3.38641311 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.34670762 |
| 48 | proteasome assembly (GO:0043248) | 3.31159067 |
| 49 | mast cell degranulation (GO:0043303) | 3.29609893 |
| 50 | mast cell activation involved in immune response (GO:0002279) | 3.29609893 |
| 51 | establishment of integrated proviral latency (GO:0075713) | 3.27535173 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26367946 |
| 53 | viral transcription (GO:0019083) | 3.26194437 |
| 54 | spliceosomal complex assembly (GO:0000245) | 3.26071519 |
| 55 | response to interleukin-15 (GO:0070672) | 3.25364810 |
| 56 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.24055846 |
| 57 | negative thymic T cell selection (GO:0045060) | 3.22322622 |
| 58 | fucose catabolic process (GO:0019317) | 3.21829476 |
| 59 | L-fucose metabolic process (GO:0042354) | 3.21829476 |
| 60 | L-fucose catabolic process (GO:0042355) | 3.21829476 |
| 61 | metaphase plate congression (GO:0051310) | 3.21133854 |
| 62 | metallo-sulfur cluster assembly (GO:0031163) | 3.20851817 |
| 63 | iron-sulfur cluster assembly (GO:0016226) | 3.20851817 |
| 64 | translational termination (GO:0006415) | 3.20065587 |
| 65 | establishment of viral latency (GO:0019043) | 3.19727784 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19668298 |
| 67 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.19574657 |
| 68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.19563799 |
| 69 | CENP-A containing nucleosome assembly (GO:0034080) | 3.18328798 |
| 70 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.17381659 |
| 71 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.17381659 |
| 72 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.16804900 |
| 73 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.16804900 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.16804900 |
| 75 | ribosomal small subunit biogenesis (GO:0042274) | 3.16582624 |
| 76 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.15530256 |
| 77 | spliceosomal snRNP assembly (GO:0000387) | 3.13057429 |
| 78 | ribosomal small subunit assembly (GO:0000028) | 3.12409132 |
| 79 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11789562 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11789562 |
| 81 | regulation of gamma-delta T cell activation (GO:0046643) | 3.11663644 |
| 82 | purine nucleobase biosynthetic process (GO:0009113) | 3.11331624 |
| 83 | regulation of T cell apoptotic process (GO:0070232) | 3.11071075 |
| 84 | * telomere maintenance via telomere lengthening (GO:0010833) | 3.09394038 |
| 85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.08363103 |
| 86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08334011 |
| 87 | chromatin remodeling at centromere (GO:0031055) | 3.07213702 |
| 88 | viral mRNA export from host cell nucleus (GO:0046784) | 3.07086200 |
| 89 | positive regulation of ligase activity (GO:0051351) | 3.06516019 |
| 90 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06153797 |
| 91 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06153797 |
| 92 | mitotic nuclear envelope disassembly (GO:0007077) | 3.05655981 |
| 93 | 7-methylguanosine mRNA capping (GO:0006370) | 3.05410621 |
| 94 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.04707503 |
| 95 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.04544401 |
| 96 | cell cycle G1/S phase transition (GO:0044843) | 3.04544401 |
| 97 | translational initiation (GO:0006413) | 3.03783682 |
| 98 | positive thymic T cell selection (GO:0045059) | 3.03363675 |
| 99 | adenosine metabolic process (GO:0046085) | 3.02526970 |
| 100 | RNA capping (GO:0036260) | 3.02066023 |
| 101 | 7-methylguanosine RNA capping (GO:0009452) | 3.02066023 |
| 102 | ribosome assembly (GO:0042255) | 3.00423064 |
| 103 | establishment of chromosome localization (GO:0051303) | 3.00374778 |
| 104 | leukocyte degranulation (GO:0043299) | 2.98454647 |
| 105 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.97958979 |
| 106 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.97790675 |
| 107 | eosinophil chemotaxis (GO:0048245) | 2.97575135 |
| 108 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.97208841 |
| 109 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.97208841 |
| 110 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.97208841 |
| 111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97051210 |
| 112 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.96742108 |
| 113 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.96737560 |
| 114 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.96014604 |
| 115 | ribosome biogenesis (GO:0042254) | 2.95806940 |
| 116 | vesicle fusion (GO:0006906) | 2.95464449 |
| 117 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91795328 |
| 118 | sequestering of actin monomers (GO:0042989) | 2.89294967 |
| 119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89241650 |
| 120 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88936548 |
| 121 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88936548 |
| 122 | cytidine metabolic process (GO:0046087) | 2.88613226 |
| 123 | cytidine catabolic process (GO:0006216) | 2.88613226 |
| 124 | cytidine deamination (GO:0009972) | 2.88613226 |
| 125 | rRNA processing (GO:0006364) | 2.88303375 |
| 126 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.88293441 |
| 127 | translational elongation (GO:0006414) | 2.88202568 |
| 128 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.88033953 |
| 129 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87605180 |
| 130 | cellular response to interferon-beta (GO:0035458) | 2.85428651 |
| 131 | macrophage chemotaxis (GO:0048246) | 2.85270321 |
| 132 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84602168 |
| 133 | kinetochore organization (GO:0051383) | 2.83562570 |
| 134 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.83390113 |
| 135 | ribosomal large subunit biogenesis (GO:0042273) | 2.83226539 |
| 136 | T cell migration (GO:0072678) | 2.81830155 |
| 137 | regulation of ligase activity (GO:0051340) | 2.81677351 |
| 138 | peptidyl-histidine modification (GO:0018202) | 2.81632022 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.80945158 |
| 140 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.80682616 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80269604 |
| 142 | purine nucleotide salvage (GO:0032261) | 2.80249374 |
| 143 | membrane disassembly (GO:0030397) | 2.77577383 |
| 144 | nuclear envelope disassembly (GO:0051081) | 2.77577383 |
| 145 | rRNA metabolic process (GO:0016072) | 2.77225755 |
| 146 | DNA replication-independent nucleosome organization (GO:0034724) | 2.75632266 |
| 147 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.75632266 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.75418108 |
| 149 | blastocyst development (GO:0001824) | 2.75278189 |
| 150 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.74811022 |
| 151 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.74811022 |
| 152 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.74811022 |
| 153 | negative regulation of sister chromatid segregation (GO:0033046) | 2.74811022 |
| 154 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.74433893 |
| 155 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.73328575 |
| 156 | cotranslational protein targeting to membrane (GO:0006613) | 2.72923435 |
| 157 | negative regulation of chromosome segregation (GO:0051985) | 2.72229440 |
| 158 | eosinophil migration (GO:0072677) | 2.71600742 |
| 159 | termination of RNA polymerase I transcription (GO:0006363) | 2.70866433 |
| 160 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.70751751 |
| 161 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.70751579 |
| 162 | spindle checkpoint (GO:0031577) | 2.70682417 |
| 163 | regulation of B cell differentiation (GO:0045577) | 2.70599281 |
| 164 | positive regulation of cell cycle arrest (GO:0071158) | 2.69568734 |
| 165 | positive T cell selection (GO:0043368) | 2.69355035 |
| 166 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.68970354 |
| 167 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.68756318 |
| 168 | mitotic spindle assembly checkpoint (GO:0007094) | 2.67468295 |
| 169 | DNA damage response, detection of DNA damage (GO:0042769) | 2.67414651 |
| 170 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67011149 |
| 171 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.66709716 |
| 172 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.60713957 |
| 173 | actin nucleation (GO:0045010) | 2.60614283 |
| 174 | regulation of lymphocyte apoptotic process (GO:0070228) | 2.60560991 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60318459 |
| 176 | negative regulation of Ras GTPase activity (GO:0034261) | 2.59216028 |
| 177 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.57910081 |
| 178 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.57910081 |
| 179 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.55888572 |
| 180 | negative regulation of innate immune response (GO:0045824) | 2.54449416 |
| 181 | neutrophil activation involved in immune response (GO:0002283) | 2.53160329 |
| 182 | T cell receptor signaling pathway (GO:0050852) | 2.52377226 |
| 183 | regulation of interleukin-8 secretion (GO:2000482) | 2.46011277 |
| 184 | purine-containing compound salvage (GO:0043101) | 2.46008277 |
| 185 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.45025935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.87740161 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60393159 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.23451541 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.74714216 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.51267091 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.38412909 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.35426228 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34512306 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.26779001 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.26246968 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.20588892 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.17997458 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.08368172 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03354394 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.97537921 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.96906683 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95630991 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87991608 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.81233611 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.80552754 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.79360204 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76916109 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.74920760 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.72456901 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.71947888 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62402310 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.58912565 |
| 28 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.48653498 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 2.46235281 |
| 30 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.42200770 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.39140774 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39010114 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.35106959 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29542679 |
| 35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22473786 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.13353234 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.07470368 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00276115 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.96989358 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96167201 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.95899299 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94807491 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94210065 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92081506 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90819020 |
| 46 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.89645468 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.89271517 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.84858137 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83805784 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80115726 |
| 51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79278294 |
| 52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77256221 |
| 53 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.73691748 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72074798 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70946063 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.67664499 |
| 57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.66788184 |
| 58 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66543336 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.64622370 |
| 60 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64316644 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.63581578 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62431822 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61707779 |
| 64 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60846313 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60284455 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58984077 |
| 67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57903136 |
| 68 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57565560 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55289318 |
| 70 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.51421566 |
| 71 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49171561 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.48554485 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48387790 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47176086 |
| 75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47081070 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46774601 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42812130 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39754821 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39290282 |
| 80 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.36513990 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34843908 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34459911 |
| 83 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.34240931 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33530162 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32382770 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32156854 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29730786 |
| 88 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28085547 |
| 89 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.26683349 |
| 90 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26544943 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24830887 |
| 92 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24583497 |
| 93 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.23883848 |
| 94 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23316921 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23176926 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22312110 |
| 97 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.21981511 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20696689 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20275887 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19903019 |
| 101 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.19768757 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.19124480 |
| 103 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18741702 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18052866 |
| 105 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16622338 |
| 106 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15016436 |
| 107 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10517246 |
| 108 | * MAF_26560356_Chip-Seq_TH1_Human | 1.10119759 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10007341 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09453684 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09417111 |
| 112 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04753654 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03316784 |
| 114 | MAF_26560356_Chip-Seq_TH2_Human | 1.02341763 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00243320 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99973204 |
| 117 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99918322 |
| 118 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.99283158 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98703494 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98154028 |
| 121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97732102 |
| 122 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97611872 |
| 123 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97022144 |
| 124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96959245 |
| 125 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95595318 |
| 126 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95558377 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94937555 |
| 128 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94317111 |
| 129 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94260149 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92865126 |
| 131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92672315 |
| 132 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92240398 |
| 133 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92093099 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92074094 |
| 135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91099588 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90876845 |
| 137 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90669435 |
| 138 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90577774 |
| 139 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89671674 |
| 140 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89584632 |
| 141 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.88847180 |
| 142 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88650712 |
| 143 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88211439 |
| 144 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87076430 |
| 145 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86939125 |
| 146 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.86126179 |
| 147 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85882576 |
| 148 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85792686 |
| 149 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83306188 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83249280 |
| 151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82801788 |
| 152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82701110 |
| 153 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80775801 |
| 154 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.80337290 |
| 155 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.78966471 |
| 156 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78102577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 3.66937618 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.58079410 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.53579175 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.38567698 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.23281821 |
| 6 | MP0003077_abnormal_cell_cycle | 3.23121673 |
| 7 | MP0008057_abnormal_DNA_replication | 3.02360336 |
| 8 | MP0008058_abnormal_DNA_repair | 3.01190912 |
| 9 | MP0003724_increased_susceptibility_to | 2.95823247 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.80628306 |
| 11 | MP0006082_CNS_inflammation | 2.60945112 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.54997996 |
| 13 | MP0003436_decreased_susceptibility_to | 2.54448992 |
| 14 | MP0009785_altered_susceptibility_to | 2.53661170 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.52714892 |
| 16 | MP0003303_peritoneal_inflammation | 2.52072984 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.51696900 |
| 18 | MP0008932_abnormal_embryonic_tissue | 2.46873897 |
| 19 | MP0001800_abnormal_humoral_immune | 2.46503619 |
| 20 | MP0000685_abnormal_immune_system | 2.35146475 |
| 21 | MP0002723_abnormal_immune_serum | 2.23456197 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.21197164 |
| 23 | MP0000537_abnormal_urethra_morphology | 2.20511916 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.20442984 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.20268975 |
| 26 | MP0010030_abnormal_orbit_morphology | 2.18733189 |
| 27 | MP0001819_abnormal_immune_cell | 2.17951914 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 2.13616275 |
| 29 | MP0005025_abnormal_response_to | 2.13218705 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.13025594 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.10657624 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 2.09451372 |
| 33 | MP0002006_tumorigenesis | 2.05222169 |
| 34 | MP0002419_abnormal_innate_immunity | 1.93752088 |
| 35 | MP0001730_embryonic_growth_arrest | 1.92892423 |
| 36 | MP0005387_immune_system_phenotype | 1.91818444 |
| 37 | MP0001790_abnormal_immune_system | 1.91818444 |
| 38 | MP0003786_premature_aging | 1.91117372 |
| 39 | MP0003123_paternal_imprinting | 1.91050217 |
| 40 | MP0003718_maternal_effect | 1.87441561 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.72950418 |
| 42 | MP0000716_abnormal_immune_system | 1.69997127 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.68407806 |
| 44 | MP0003315_abnormal_perineum_morphology | 1.66700177 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.66355260 |
| 46 | MP0004133_heterotaxia | 1.65247319 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.61697092 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.60979233 |
| 49 | MP0003866_abnormal_defecation | 1.57660772 |
| 50 | MP0005671_abnormal_response_to | 1.49535622 |
| 51 | MP0002429_abnormal_blood_cell | 1.42569525 |
| 52 | MP0002249_abnormal_larynx_morphology | 1.39254112 |
| 53 | MP0000049_abnormal_middle_ear | 1.38859682 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.36534525 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.36316303 |
| 56 | MP0002085_abnormal_embryonic_tissue | 1.36020765 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.35241453 |
| 58 | MP0008469_abnormal_protein_level | 1.34384928 |
| 59 | MP0002132_abnormal_respiratory_system | 1.33389753 |
| 60 | MP0001663_abnormal_digestive_system | 1.32589375 |
| 61 | MP0002102_abnormal_ear_morphology | 1.32109971 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.31515176 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.31515176 |
| 64 | MP0009697_abnormal_copulation | 1.29504091 |
| 65 | MP0004147_increased_porphyrin_level | 1.28799906 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.27643295 |
| 67 | MP0005380_embryogenesis_phenotype | 1.27643295 |
| 68 | MP0003941_abnormal_skin_development | 1.26567793 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.26447204 |
| 70 | MP0005171_absent_coat_pigmentation | 1.25710789 |
| 71 | MP0003828_pulmonary_edema | 1.24585266 |
| 72 | MP0001697_abnormal_embryo_size | 1.24299784 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 1.23995023 |
| 74 | MP0003121_genomic_imprinting | 1.23238946 |
| 75 | MP0009764_decreased_sensitivity_to | 1.22848198 |
| 76 | MP0005166_decreased_susceptibility_to | 1.22836322 |
| 77 | MP0002938_white_spotting | 1.19948736 |
| 78 | MP0003938_abnormal_ear_development | 1.19722170 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19579938 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 1.17456931 |
| 81 | MP0002084_abnormal_developmental_patter | 1.16206461 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 1.15036181 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.14543663 |
| 84 | MP0005367_renal/urinary_system_phenotyp | 1.13790564 |
| 85 | MP0000516_abnormal_urinary_system | 1.13790564 |
| 86 | MP0002080_prenatal_lethality | 1.13664583 |
| 87 | MP0001873_stomach_inflammation | 1.13089516 |
| 88 | MP0001529_abnormal_vocalization | 1.11915780 |
| 89 | MP0003119_abnormal_digestive_system | 1.11785933 |
| 90 | MP0003984_embryonic_growth_retardation | 1.11037627 |
| 91 | MP0003279_aneurysm | 1.10695550 |
| 92 | MP0001664_abnormal_digestion | 1.06735477 |
| 93 | MP0008877_abnormal_DNA_methylation | 1.06627833 |
| 94 | MP0002405_respiratory_system_inflammati | 1.06617824 |
| 95 | MP0000703_abnormal_thymus_morphology | 1.05471762 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 1.05443714 |
| 97 | MP0004272_abnormal_basement_membrane | 1.04595425 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 1.03728652 |
| 99 | MP0001293_anophthalmia | 1.03569233 |
| 100 | MP0000313_abnormal_cell_death | 1.02972356 |
| 101 | MP0005503_abnormal_tendon_morphology | 1.01339662 |
| 102 | MP0000566_synostosis | 1.00968493 |
| 103 | MP0009763_increased_sensitivity_to | 1.00080734 |
| 104 | MP0004043_abnormal_pH_regulation | 0.99794231 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.99440520 |
| 106 | MP0005165_increased_susceptibility_to | 0.99301716 |
| 107 | MP0008438_abnormal_cutaneous_collagen | 0.98753298 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.98635998 |
| 109 | MP0008260_abnormal_autophagy | 0.98113313 |
| 110 | MP0005023_abnormal_wound_healing | 0.96473144 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.96175539 |
| 112 | MP0002086_abnormal_extraembryonic_tissu | 0.95177035 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94958214 |
| 114 | MP0004947_skin_inflammation | 0.94920032 |
| 115 | MP0001853_heart_inflammation | 0.92757195 |
| 116 | MP0000490_abnormal_crypts_of | 0.92434272 |
| 117 | MP0002111_abnormal_tail_morphology | 0.92251213 |
| 118 | MP0003252_abnormal_bile_duct | 0.90818164 |
| 119 | MP0002653_abnormal_ependyma_morphology | 0.90467719 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.89340565 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.88651578 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.87791982 |
| 123 | MP0005083_abnormal_biliary_tract | 0.87536254 |
| 124 | MP0003075_altered_response_to | 0.86924856 |
| 125 | MP0003942_abnormal_urinary_system | 0.86470879 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.85161175 |
| 127 | MP0003186_abnormal_redox_activity | 0.84837026 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.84800188 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.84596651 |
| 130 | MP0001919_abnormal_reproductive_system | 0.84364263 |
| 131 | MP0005164_abnormal_response_to | 0.82987829 |
| 132 | MP0001764_abnormal_homeostasis | 0.81373541 |
| 133 | MP0001243_abnormal_dermal_layer | 0.81347929 |
| 134 | MP0003755_abnormal_palate_morphology | 0.80936420 |
| 135 | MP0002932_abnormal_joint_morphology | 0.80888404 |
| 136 | MP0002163_abnormal_gland_morphology | 0.80632972 |
| 137 | MP0000858_altered_metastatic_potential | 0.80513948 |
| 138 | MP0003136_yellow_coat_color | 0.80264475 |
| 139 | MP0002722_abnormal_immune_system | 0.80137886 |
| 140 | MP0001851_eye_inflammation | 0.80115987 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.79995438 |
| 142 | MP0001286_abnormal_eye_development | 0.79570900 |
| 143 | MP0002210_abnormal_sex_determination | 0.79242845 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.78602358 |
| 145 | MP0005174_abnormal_tail_pigmentation | 0.78543369 |
| 146 | MP0003385_abnormal_body_wall | 0.78402554 |
| 147 | MP0004484_altered_response_of | 0.77755756 |
| 148 | MP0001542_abnormal_bone_strength | 0.77063752 |
| 149 | MP0002127_abnormal_cardiovascular_syste | 0.76027622 |
| 150 | MP0008872_abnormal_physiological_respon | 0.75373865 |
| 151 | MP0002398_abnormal_bone_marrow | 0.75125279 |
| 152 | MP0005508_abnormal_skeleton_morphology | 0.74956157 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.74031838 |
| 154 | MP0002751_abnormal_autonomic_nervous | 0.73960724 |
| 155 | MP0002332_abnormal_exercise_endurance | 0.73920555 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.73905129 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.73819836 |
| 158 | MP0009840_abnormal_foam_cell | 0.73629136 |
| 159 | MP0000015_abnormal_ear_pigmentation | 0.73206669 |
| 160 | MP0005409_darkened_coat_color | 0.72633450 |
| 161 | MP0000689_abnormal_spleen_morphology | 0.72476124 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.72430964 |
| 163 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71593471 |
| 164 | MP0002114_abnormal_axial_skeleton | 0.71512036 |
| 165 | MP0002138_abnormal_hepatobiliary_system | 0.71195760 |
| 166 | MP0000343_altered_response_to | 0.69654350 |
| 167 | MP0005389_reproductive_system_phenotype | 0.69596427 |
| 168 | MP0004381_abnormal_hair_follicle | 0.69078649 |
| 169 | MP0005390_skeleton_phenotype | 0.67799818 |
| 170 | MP0001145_abnormal_male_reproductive | 0.67667531 |
| 171 | MP0010386_abnormal_urinary_bladder | 0.67008873 |
| 172 | MP0000358_abnormal_cell_content/ | 0.66528761 |
| 173 | MP0003448_altered_tumor_morphology | 0.65991155 |
| 174 | MP0000432_abnormal_head_morphology | 0.65746727 |
| 175 | MP0009379_abnormal_foot_pigmentation | 0.64931481 |
| 176 | MP0002933_joint_inflammation | 0.64171574 |
| 177 | MP0010368_abnormal_lymphatic_system | 0.63658410 |
| 178 | MP0003936_abnormal_reproductive_system | 0.62600032 |
| 179 | MP0000767_abnormal_smooth_muscle | 0.61517559 |
| 180 | MP0006054_spinal_hemorrhage | 0.61407382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32654262 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.07915136 |
| 3 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.95087533 |
| 4 | Breast hypoplasia (HP:0003187) | 3.58238175 |
| 5 | Stomatitis (HP:0010280) | 3.56634205 |
| 6 | Selective tooth agenesis (HP:0001592) | 3.38196671 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.37306237 |
| 8 | Cerebral hypomyelination (HP:0006808) | 3.33989867 |
| 9 | Reticulocytopenia (HP:0001896) | 3.21475118 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17116908 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.11911139 |
| 12 | Abnormal number of incisors (HP:0011064) | 3.08548612 |
| 13 | Abnormality of T cells (HP:0002843) | 3.07256864 |
| 14 | Stenosis of the external auditory canal (HP:0000402) | 2.99612435 |
| 15 | Hypoproteinemia (HP:0003075) | 2.91506251 |
| 16 | Rhabdomyolysis (HP:0003201) | 2.86167580 |
| 17 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.85409422 |
| 18 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.85409422 |
| 19 | Single umbilical artery (HP:0001195) | 2.85409422 |
| 20 | Patellar aplasia (HP:0006443) | 2.76770407 |
| 21 | Dry hair (HP:0011359) | 2.75757147 |
| 22 | Abnormal lung lobation (HP:0002101) | 2.75292595 |
| 23 | Abnormality of the umbilical cord (HP:0010881) | 2.73864257 |
| 24 | Myoglobinuria (HP:0002913) | 2.71349429 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.67001152 |
| 26 | Progressive muscle weakness (HP:0003323) | 2.66542156 |
| 27 | Abnormality of the prostate (HP:0008775) | 2.64696666 |
| 28 | Supernumerary spleens (HP:0009799) | 2.59033342 |
| 29 | Thyroiditis (HP:0100646) | 2.58147684 |
| 30 | Myositis (HP:0100614) | 2.57693528 |
| 31 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.56773012 |
| 32 | Abnormality of eosinophils (HP:0001879) | 2.55969361 |
| 33 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.55505936 |
| 34 | Meckel diverticulum (HP:0002245) | 2.55150812 |
| 35 | Palpitations (HP:0001962) | 2.53818892 |
| 36 | Absent radius (HP:0003974) | 2.51270957 |
| 37 | Large for gestational age (HP:0001520) | 2.50789847 |
| 38 | Abnormality of the ileum (HP:0001549) | 2.49656423 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48125768 |
| 40 | Rough bone trabeculation (HP:0100670) | 2.47969439 |
| 41 | IgM deficiency (HP:0002850) | 2.47063455 |
| 42 | Premature graying of hair (HP:0002216) | 2.46294822 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43361594 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43361594 |
| 45 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.41863393 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.41425473 |
| 47 | Acute hepatic failure (HP:0006554) | 2.40581490 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 2.39603518 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 2.39603518 |
| 50 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.38805448 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.37951261 |
| 52 | B lymphocytopenia (HP:0010976) | 2.37456750 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.36138072 |
| 54 | Absent forearm bone (HP:0003953) | 2.36000236 |
| 55 | Aplasia involving forearm bones (HP:0009822) | 2.36000236 |
| 56 | Abnormality of the renal collecting system (HP:0004742) | 2.32614248 |
| 57 | Chronic diarrhea (HP:0002028) | 2.31115157 |
| 58 | Asplenia (HP:0001746) | 2.30999850 |
| 59 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30403142 |
| 60 | Brushfield spots (HP:0001088) | 2.29809645 |
| 61 | Lactic acidosis (HP:0003128) | 2.29064269 |
| 62 | Renal cortical cysts (HP:0000803) | 2.28606862 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.27523300 |
| 64 | Increased serum pyruvate (HP:0003542) | 2.27513327 |
| 65 | Abnormality of glycolysis (HP:0004366) | 2.27513327 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27294476 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27294476 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.27294476 |
| 69 | Abnormal glycosylation (HP:0012345) | 2.27294476 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.26676982 |
| 71 | Menstrual irregularities (HP:0000858) | 2.25684107 |
| 72 | Abnormality of the preputium (HP:0100587) | 2.25585234 |
| 73 | Carpal bone hypoplasia (HP:0001498) | 2.24488260 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.22898729 |
| 75 | Macrocytic anemia (HP:0001972) | 2.21649840 |
| 76 | Microretrognathia (HP:0000308) | 2.21288356 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20678351 |
| 78 | Pustule (HP:0200039) | 2.19928384 |
| 79 | Granulocytopenia (HP:0001913) | 2.19255902 |
| 80 | Duodenal stenosis (HP:0100867) | 2.19091170 |
| 81 | Small intestinal stenosis (HP:0012848) | 2.19091170 |
| 82 | Encephalitis (HP:0002383) | 2.17821023 |
| 83 | Metaphyseal dysplasia (HP:0100255) | 2.17451935 |
| 84 | Eosinophilia (HP:0001880) | 2.16885835 |
| 85 | Joint swelling (HP:0001386) | 2.14982314 |
| 86 | Hepatic necrosis (HP:0002605) | 2.14304033 |
| 87 | Colon cancer (HP:0003003) | 2.13909278 |
| 88 | Increased IgM level (HP:0003496) | 2.13704948 |
| 89 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.13233614 |
| 90 | Abnormality of the aortic arch (HP:0012303) | 2.12981821 |
| 91 | Triphalangeal thumb (HP:0001199) | 2.12661593 |
| 92 | Meningitis (HP:0001287) | 2.11775374 |
| 93 | Chromsome breakage (HP:0040012) | 2.10633353 |
| 94 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10346330 |
| 95 | Aplastic anemia (HP:0001915) | 2.08625323 |
| 96 | Absent epiphyses (HP:0010577) | 2.08562093 |
| 97 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.08562093 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07640574 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 2.07640574 |
| 100 | Abnormality of the labia minora (HP:0012880) | 2.07118635 |
| 101 | Duplicated collecting system (HP:0000081) | 2.07041038 |
| 102 | Steatorrhea (HP:0002570) | 2.06990300 |
| 103 | Petechiae (HP:0000967) | 2.05832449 |
| 104 | Vasculitis (HP:0002633) | 2.04658507 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.03677950 |
| 106 | Leukocytosis (HP:0001974) | 2.03418724 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.02900241 |
| 108 | Ectopic kidney (HP:0000086) | 2.02824132 |
| 109 | Skin rash (HP:0000988) | 2.02367298 |
| 110 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.01649102 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98578267 |
| 112 | Oral leukoplakia (HP:0002745) | 1.98413854 |
| 113 | Abnormality of chromosome stability (HP:0003220) | 1.97499025 |
| 114 | Hepatocellular necrosis (HP:0001404) | 1.97153288 |
| 115 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96669476 |
| 116 | Acute necrotizing encephalopathy (HP:0006965) | 1.96118720 |
| 117 | Decreased central vision (HP:0007663) | 1.95858932 |
| 118 | Polyneuropathy (HP:0001271) | 1.95336867 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94967028 |
| 120 | Obstructive lung disease (HP:0006536) | 1.94967028 |
| 121 | Abnormality of the alveolar ridges (HP:0006477) | 1.94953588 |
| 122 | Atresia of the external auditory canal (HP:0000413) | 1.94949645 |
| 123 | Recurrent skin infections (HP:0001581) | 1.93040925 |
| 124 | Anhidrosis (HP:0000970) | 1.92842503 |
| 125 | Recurrent abscess formation (HP:0002722) | 1.92535331 |
| 126 | Inflammation of the large intestine (HP:0002037) | 1.92462713 |
| 127 | Prostate neoplasm (HP:0100787) | 1.91986835 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.90730159 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.90067249 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.88436497 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88159826 |
| 132 | Autoamputation (HP:0001218) | 1.87205104 |
| 133 | Severe combined immunodeficiency (HP:0004430) | 1.86187499 |
| 134 | Facial cleft (HP:0002006) | 1.85581754 |
| 135 | Abnormal spermatogenesis (HP:0008669) | 1.85530258 |
| 136 | Postnatal microcephaly (HP:0005484) | 1.85159756 |
| 137 | Orchitis (HP:0100796) | 1.84895558 |
| 138 | Slender long bone (HP:0003100) | 1.84191150 |
| 139 | Glossoptosis (HP:0000162) | 1.82418828 |
| 140 | Absent thumb (HP:0009777) | 1.82386362 |
| 141 | Renal Fanconi syndrome (HP:0001994) | 1.82002618 |
| 142 | Sloping forehead (HP:0000340) | 1.81717932 |
| 143 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81420340 |
| 144 | Abnormal number of erythroid precursors (HP:0012131) | 1.80909700 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 1.80566476 |
| 146 | Trismus (HP:0000211) | 1.80465488 |
| 147 | Horseshoe kidney (HP:0000085) | 1.80229306 |
| 148 | Gangrene (HP:0100758) | 1.79219646 |
| 149 | Erythema (HP:0010783) | 1.79136449 |
| 150 | Poor head control (HP:0002421) | 1.79085605 |
| 151 | Chest pain (HP:0100749) | 1.78926406 |
| 152 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.78876811 |
| 153 | Adrenal hypoplasia (HP:0000835) | 1.78487463 |
| 154 | Pulmonary fibrosis (HP:0002206) | 1.78349350 |
| 155 | Arterial thrombosis (HP:0004420) | 1.77896044 |
| 156 | Impulsivity (HP:0100710) | 1.77892839 |
| 157 | Mitochondrial inheritance (HP:0001427) | 1.77096173 |
| 158 | Cellular immunodeficiency (HP:0005374) | 1.77004723 |
| 159 | Rectal fistula (HP:0100590) | 1.76870925 |
| 160 | Rectovaginal fistula (HP:0000143) | 1.76870925 |
| 161 | Increased CSF lactate (HP:0002490) | 1.76066224 |
| 162 | Bone marrow hypocellularity (HP:0005528) | 1.75509947 |
| 163 | Nasolacrimal duct obstruction (HP:0000579) | 1.75347277 |
| 164 | Abnormal trabecular bone morphology (HP:0100671) | 1.74297234 |
| 165 | Bilateral microphthalmos (HP:0007633) | 1.73909637 |
| 166 | Esophageal atresia (HP:0002032) | 1.73227732 |
| 167 | Optic nerve coloboma (HP:0000588) | 1.72995043 |
| 168 | Embryonal renal neoplasm (HP:0011794) | 1.72726079 |
| 169 | Proximal placement of thumb (HP:0009623) | 1.71267577 |
| 170 | IgG deficiency (HP:0004315) | 1.70476209 |
| 171 | Abnormality of the duodenum (HP:0002246) | 1.70190438 |
| 172 | Ureteral duplication (HP:0000073) | 1.69289548 |
| 173 | Increased hepatocellular lipid droplets (HP:0006565) | 1.69254743 |
| 174 | Combined immunodeficiency (HP:0005387) | 1.69198571 |
| 175 | Cleft eyelid (HP:0000625) | 1.67825482 |
| 176 | Muscle fiber atrophy (HP:0100295) | 1.67653526 |
| 177 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.67153559 |
| 178 | Neoplasm of the pancreas (HP:0002894) | 1.65038135 |
| 179 | Increased serum lactate (HP:0002151) | 1.64656341 |
| 180 | Congenital malformation of the right heart (HP:0011723) | 1.64628776 |
| 181 | Double outlet right ventricle (HP:0001719) | 1.64628776 |
| 182 | Spinal muscular atrophy (HP:0007269) | 1.64520958 |
| 183 | Pallor (HP:0000980) | 1.64445321 |
| 184 | Deviation of the thumb (HP:0009603) | 1.64285714 |
| 185 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.64216496 |
| 186 | T lymphocytopenia (HP:0005403) | 1.63417686 |
| 187 | Respiratory difficulties (HP:0002880) | 1.63102900 |
| 188 | Type I transferrin isoform profile (HP:0003642) | 1.62763936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.38809971 |
| 2 | WEE1 | 3.73058035 |
| 3 | MAP4K2 | 3.47994880 |
| 4 | TESK2 | 2.79526588 |
| 5 | BCKDK | 2.61740187 |
| 6 | TSSK6 | 2.52140524 |
| 7 | MAP3K11 | 2.51760853 |
| 8 | TAOK3 | 2.46756736 |
| 9 | EIF2AK1 | 2.45621522 |
| 10 | CDC7 | 2.41001796 |
| 11 | JAK3 | 2.32428187 |
| 12 | KDR | 2.32218062 |
| 13 | TLK1 | 2.12538377 |
| 14 | MAP2K3 | 2.11586585 |
| 15 | GRK6 | 2.10085515 |
| 16 | VRK1 | 2.09814752 |
| 17 | PBK | 2.03868649 |
| 18 | NME2 | 1.97081366 |
| 19 | MAP3K12 | 1.94846255 |
| 20 | MKNK1 | 1.94578889 |
| 21 | PASK | 1.91269311 |
| 22 | EIF2AK3 | 1.85779275 |
| 23 | STK10 | 1.85564326 |
| 24 | MST4 | 1.82550443 |
| 25 | TBK1 | 1.73777625 |
| 26 | TAOK1 | 1.70805156 |
| 27 | SRPK1 | 1.69950633 |
| 28 | KIT | 1.62235354 |
| 29 | PLK4 | 1.58061238 |
| 30 | EPHA2 | 1.57991132 |
| 31 | PLK1 | 1.57801508 |
| 32 | STK16 | 1.57248909 |
| 33 | MKNK2 | 1.57122620 |
| 34 | PLK3 | 1.52632527 |
| 35 | CDK7 | 1.51700039 |
| 36 | TGFBR1 | 1.51256381 |
| 37 | LIMK1 | 1.48967006 |
| 38 | IKBKE | 1.46448937 |
| 39 | SCYL2 | 1.44758434 |
| 40 | RIPK4 | 1.44722386 |
| 41 | VRK2 | 1.40111965 |
| 42 | ZAK | 1.37017610 |
| 43 | TTK | 1.36319226 |
| 44 | ACVR1B | 1.34103746 |
| 45 | TESK1 | 1.33004094 |
| 46 | TXK | 1.32216901 |
| 47 | TAOK2 | 1.30936410 |
| 48 | AURKB | 1.30310799 |
| 49 | PIM2 | 1.29302650 |
| 50 | MAP3K14 | 1.29138683 |
| 51 | BCR | 1.27410439 |
| 52 | BRSK2 | 1.23637622 |
| 53 | FES | 1.23419004 |
| 54 | NEK2 | 1.20209218 |
| 55 | CSF1R | 1.16629683 |
| 56 | ZAP70 | 1.15018743 |
| 57 | NME1 | 1.13902198 |
| 58 | AURKA | 1.13854281 |
| 59 | MAP3K8 | 1.11083835 |
| 60 | NUAK1 | 1.08502982 |
| 61 | ATR | 1.05820741 |
| 62 | SYK | 1.03992475 |
| 63 | PAK4 | 1.03026871 |
| 64 | FLT3 | 1.02657165 |
| 65 | IKBKB | 1.02263533 |
| 66 | CSK | 1.00001589 |
| 67 | PRKCQ | 0.99857945 |
| 68 | EIF2AK2 | 0.97727422 |
| 69 | BMPR2 | 0.96549962 |
| 70 | TIE1 | 0.96324111 |
| 71 | PIK3CG | 0.94975227 |
| 72 | CDK19 | 0.94048097 |
| 73 | CLK1 | 0.93918487 |
| 74 | TNK2 | 0.93097694 |
| 75 | MAP3K5 | 0.92038944 |
| 76 | BMPR1B | 0.91687410 |
| 77 | JAK1 | 0.91298034 |
| 78 | LRRK2 | 0.90516459 |
| 79 | DYRK2 | 0.87902067 |
| 80 | ABL2 | 0.87173570 |
| 81 | STK4 | 0.85507807 |
| 82 | RPS6KB2 | 0.83109591 |
| 83 | NEK1 | 0.81884001 |
| 84 | CHEK2 | 0.80689675 |
| 85 | PAK1 | 0.78325655 |
| 86 | MYLK | 0.77053148 |
| 87 | ITK | 0.76373746 |
| 88 | RPS6KA4 | 0.76368999 |
| 89 | BRAF | 0.72642826 |
| 90 | DAPK1 | 0.71832375 |
| 91 | MAPKAPK3 | 0.71277195 |
| 92 | LYN | 0.70683434 |
| 93 | MAP3K1 | 0.70286229 |
| 94 | MUSK | 0.69977488 |
| 95 | MATK | 0.69716824 |
| 96 | MAP4K1 | 0.69701316 |
| 97 | BRSK1 | 0.68945910 |
| 98 | TYK2 | 0.68727353 |
| 99 | GRK7 | 0.67732242 |
| 100 | DYRK3 | 0.67070398 |
| 101 | CHEK1 | 0.64720617 |
| 102 | CSNK2A1 | 0.64577420 |
| 103 | CDK8 | 0.63543478 |
| 104 | TEC | 0.61660745 |
| 105 | STK39 | 0.61497867 |
| 106 | PRKCI | 0.60011659 |
| 107 | MAP2K2 | 0.59934888 |
| 108 | CSNK2A2 | 0.59817193 |
| 109 | MELK | 0.56921039 |
| 110 | TRPM7 | 0.56839987 |
| 111 | FRK | 0.55550775 |
| 112 | YES1 | 0.54586536 |
| 113 | EPHB2 | 0.54216948 |
| 114 | HCK | 0.54098008 |
| 115 | FGFR1 | 0.53538345 |
| 116 | MAP3K3 | 0.52894469 |
| 117 | PIM1 | 0.52400262 |
| 118 | MST1R | 0.52315996 |
| 119 | MET | 0.52050099 |
| 120 | BTK | 0.51234695 |
| 121 | CCNB1 | 0.51059380 |
| 122 | PLK2 | 0.50157179 |
| 123 | ATM | 0.48055853 |
| 124 | AKT3 | 0.47563368 |
| 125 | PDK2 | 0.46147932 |
| 126 | IGF1R | 0.45768786 |
| 127 | RPS6KA5 | 0.45463272 |
| 128 | TGFBR2 | 0.44835719 |
| 129 | CDK2 | 0.44122002 |
| 130 | CDK18 | 0.43049056 |
| 131 | CDK1 | 0.42985215 |
| 132 | PTK2B | 0.42471448 |
| 133 | CDK11A | 0.42438769 |
| 134 | TNIK | 0.41237207 |
| 135 | PNCK | 0.41178294 |
| 136 | OBSCN | 0.39831485 |
| 137 | ROCK2 | 0.39633776 |
| 138 | ADRBK2 | 0.39546032 |
| 139 | STK38L | 0.39205469 |
| 140 | ADRBK1 | 0.38941378 |
| 141 | LCK | 0.38806840 |
| 142 | CDK15 | 0.38338529 |
| 143 | GRK1 | 0.37852459 |
| 144 | IRAK4 | 0.37551087 |
| 145 | CASK | 0.36659336 |
| 146 | ILK | 0.36275925 |
| 147 | CDK3 | 0.36205569 |
| 148 | ABL1 | 0.35367246 |
| 149 | OXSR1 | 0.35042537 |
| 150 | CDK14 | 0.33539806 |
| 151 | MARK3 | 0.33062407 |
| 152 | LMTK2 | 0.29620925 |
| 153 | PHKG2 | 0.28630636 |
| 154 | PHKG1 | 0.28630636 |
| 155 | ERN1 | 0.26809502 |
| 156 | MAPKAPK2 | 0.25941374 |
| 157 | ERBB3 | 0.24222164 |
| 158 | NEK6 | 0.22586455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.12967510 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.90281130 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.54406724 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.33827137 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.30753844 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.28598755 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.99898485 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.89527409 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.86592792 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.71720715 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.52734090 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.51731659 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.36936519 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.17807999 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15921565 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12073782 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06362114 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94500401 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.92018384 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.69686471 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.67409525 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51586401 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41411491 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40878407 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38384815 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36774594 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.36769053 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32405240 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.32185008 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29724843 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28732575 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28592912 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28209043 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26586154 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24779447 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22527757 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.18851520 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18354031 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15144482 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12650097 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09962599 |
| 42 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09686038 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.06835447 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05787226 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05665101 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.99801908 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97550681 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89886791 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89799989 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88399806 |
| 51 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86747055 |
| 52 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.84285590 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81518974 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80405425 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77451136 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76395569 |
| 57 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76005127 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75990297 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74945212 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74798229 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74102128 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.71840677 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70875111 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69901812 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69065658 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68491420 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68164017 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66473671 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63983421 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.63360776 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.62760372 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62744376 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62687058 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.62265409 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61460172 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61166971 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.59476095 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58612760 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58531425 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57641233 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56936759 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56343206 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.56165152 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55656249 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54752369 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53639719 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53106141 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51606711 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50411884 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50384122 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49920645 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48394862 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47859925 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46561343 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46273024 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45442455 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45376049 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44989597 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44913877 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.43272874 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43030878 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41858601 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41648605 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41443264 |
| 105 | Phototransduction_Homo sapiens_hsa04744 | 0.41310084 |
| 106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40486118 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.40176535 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.40126485 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39456109 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39101814 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39066827 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.38967535 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38822428 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.38192953 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38084660 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38077495 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37546432 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37450365 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37417008 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.37184565 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35648694 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35078426 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34869692 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33729057 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33026196 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31829587 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31656594 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30971149 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30679932 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30596251 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.30589548 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30041016 |
| 133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29361647 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29046438 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27297716 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26625312 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26613967 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25532629 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.23494420 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22731239 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21730937 |
| 142 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18950481 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18337066 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18055574 |

